Fortrea | Sustainability Performance
Provides clinical trial services and solutions to the pharmaceutical industry.
1996
United Kingdom
10,001+ employees
Biotechnology
$1B - 10B in revenue
Not profitable
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#2365
Overallⓘ#277
in United Kingdomⓘ#37
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Controversy level
- Fortrea Holdings Inc, US major CRO (Labcorp clinical development spinoff 2023), has faced multiple US class actions over the contested 2023 Labcorp spinoff and the contested 2024 sustained share price collapse amid disclosed material US/global biopharma customer demand normalization following the contested historic 2023 Endo Pharmaceuticals customer concentration disputes affecting US institutional shareholders amid global CRO sector pressure.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
11+
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.